This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Evidence-based Complementary and Alternative Medicine published an article titled “Post-Traumatic Stress Disorder: Evidence-Based Research for the Third Millennium” which describes how profound the symptoms of PTSD can be: “Traumatic events are profoundly stressful. Women tend to experience different traumas than men.
Post-Traumatic Stress Disorder (PTSD) is a multifaceted mental health condition triggered by experiencing or witnessing traumatic events, persistently manifesting in symptoms like flashbacks, severe anxiety, and disrupted sleep. Looking ahead, the future of medical cannabis in PTSD treatment hinges on overcoming these challenges.
of their dry weight and it is not practical to obtain meaningful pure amounts of these compounds from the flesh of mushrooms, at a reasonable cost, to conduct clinicaltrials in humans and to commercialize these products. FDA approved guidelines for clinical studies. SOURCE Nova Mentis Life Science Corp.
ClinicalTrial Sample Size. The trial was conducted with just 186 participants, which is far too small of a sample size to provide findings generalizable to the larger population. We’ll never know for certain whether this article was intentionally designed to scare potential MMJ patients away.
9 In a February 2021 article in Nutritional Outlook , Jesse Karagianes, vice president of sales of the CBD natural products company CV Sciences (San Diego, California), was quoted as saying: “[T]he single largest factor which contributed to slow category sales was the deluge of inferior products hitting the market. Accessed July 25, 2021.
This study summarizes potential adverse drug events related to THC when combined with other medications Medicinal Use of Marijuana Cannabis has been used widely across North America in various state or provincial medical marijuana programs. However, in some cases, the risks may outweigh even the proven benefits.
This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinicaltrials assessing the safety and efficacy of CBD in various populations. National Institute of Health.
In the event that the Maximum LTV is exceeded, Brown Shipley can make a call on the Guarantors requiring them to place cash with Brown Shipley for the aggregate amount of the excess exposure over the Maximum LTV. OCT is conducting pre-clinical testing and development with pre-clinicaltrials scheduled for 2022.
This renewed interest in psychedelics is being sparked by a pair of seemingly unrelated events. So, there’s no overarching reason to think psychedelics can’t be handled in the same manner, especially if a drug successfully completes a rigorous clinicaltrial program. Hundreds of other U.S.
Accelerated timelines to clinicaltrials and expansion of drug development pipeline. Phase 1 clinicaltrials are scheduled for Q3 2022 with Phase 2 trials expected in Q2 2023. Exclusive licensing agreement with leading global cannabis company (“Canopy Growth”). the CBD, CBG or THC compounds).
and industry-leading Cannabis Business Times, Cannabis Dispensary, and Hemp Grower magazines, announces today President of Scottsdale Research Institute (SRI) Sue Sisley, MD, as the keynote speaker on Day 2 of its annual event, to take place Aug. View original article. 24-26, 2021, at Paris Las Vegas Hotel & Casino.
In this article I’ll explain how and why these interactions occur and describe the classes of medications that are processed by the same liver enzymes the body uses to process CBD. Drug interactions reported in the scientific literature most often occur at very high doses used in clinicaltrials of epilepsy and other conditions.
Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Stolar & Ilan Matok. 1), 95%CI [??1.39–(??0.60)])
The US Food and Drug Administration is also currently sponsoring clinicaltrials that could lead to the federal legalization of psilocybin- and MDMA -assisted therapy within the next two years. View original article.
This year, we are completing the second Phase 3 clinicaltrial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS continued to publish Bulletin articles about MDMA research , requests for donations , and discontinuing animal studies.
In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers. It is often caused by life events such as stress, anxiety, or a significant change in routine.
Today, 5-MeO-DMT and other psychedelic compounds including psilocybin and ketamine are gaining mainstream popularity as clinicaltrials and formal research reveal its effectiveness as an alternative mental health tool. The series of events includes retreats geared at consumers with a variety of interests and backgrounds.
As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).
With the anticipated launch of Pfizer’s oral COVID-19 antiviral drug candidate, Can-Fite has made a strategic decision to end its COVID-19 program and to focus its resources on its other clinical programs, all in advanced clinicaltrials. Can-Fite BioPharma. Motti Farbstein. info@canfite.com +972-3-9241114.
In this article, we’ll explore how CBD benefits anxiety relief. A review of clinicaltrials and meta-analyses suggests that CBD may reduce anxiety symptoms in individuals with generalized anxiety disorder (GAD), social anxiety disorder (SAD), and post-traumatic stress disorder (PTSD). Image by Suzy Hazelwood on Pexels.
This event saw doctors and researchers from all over the world presenting the scientific and clinical studies surrounding the medical benefits of cannabis. . View original article. Upon returning to Australia, it took another two years before Australia legalized cannabis for medicinal purposes.
The article argues for the implementation of nuanced risk assessment strategies for handling psychedelics in medicine, and predicts an expansion of psychedelic substances into mainstream medicine. Upcoming Events. World experts on psychedelic science, including Dr. Matt Johnson, will be speaking at the event. SMOKING CESSATION.
In this article I’ll explain how and why these interactions occur and describe the classes of medications that are processed by the same liver enzymes the body uses to process CBD. Drug interactions reported in the scientific literature most often occur at very high doses used in clinicaltrials of epilepsy and other conditions.[1].
Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. Conclusions. Background.
This service is available to businesses, K-12 schools, universities, event venues, medical offices, hospitality groups, and more to facilitate the safe return of people to in-person environments. Dalrada Health filed a patent on cerVIA™ and began its clinical screening trials in India.
While this article has been written for educational purposes, it is important to remember that this substance is listed as a Schedule 1 narcotic in the US. MDMA has also reportedly been used with over 1,000 individuals in clinicaltrials , with no adverse effects to report. . Consuming Therapeutically and Recreationally.
As yet there have been no FDA -approved clinicaltrials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. A 2014 article in American Surgeon examined how marijuana use affected people who suffered a traumatic brain injury. “A Cannabinoids to the rescue.
We were talking about, ‘What can we do with this?’ ” recalled Samantha Miller, who hosted the event at her split-level house, wedged between redwoods and a creek below. fast-tracked clinicaltrials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. Read the full article here. And because of public demand, the F.D.A.
As yet there have been no FDA -approved clinicaltrials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. A 2014 article in American Surgeon examined how marijuana use affected people who suffered a traumatic brain injury. “A Cannabinoids to the rescue.
Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinicaltrials and international studies. She is author, co-author, and co-editor of twenty-two books, two special-edition journals, and several peer-reviewed articles.
Certain medical patients, such as those participating in clinicaltrials, can gain access to cannabis under the Therapeutic Goods Act 1989, with each state having its own regulations as well. The framework for production of industrial hemp is quite different and licensing provisions are available in all states for growers.”.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content